| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.986 | 0.001 | 0.986 | Aldehyde oxidase inhibitor | 0.824 0.004 DBMET03018 0.985 0.001 DBMET00366 0.979 0.001 DBMET03023 0.976 0.001 DBMET03025 0.974 0.001 DBMET03029 0.972 0.002 DBMET03031 0.96 0.002 DBMET02136 0.986 0.001 DBMET03022 0.984 0.001 DBMET03024 0.973 0.002 DBMET03028 0.971 0.002 DBMET03030 0.968 0.002 DBMET03032 | ||
| 0.939 | 0.001 | 0.952 | Estrogen receptor alpha antagonist | 0.245 0.006 DBMET03018 0.886 0.001 DBMET00366 0.867 0.002 DBMET03023 0.931 0.001 DBMET03025 0.952 0.001 DBMET03029 0.84 0.002 DBMET03031 0.753 0.002 DBMET02136 0.803 0.002 DBMET03022 0.788 0.002 DBMET03024 0.85 0.002 DBMET03028 0.903 0.001 DBMET03030 0.778 0.002 DBMET03032 | DBMET03029 | |
| 0.883 | 0.002 | 0.945 | Androgen antagonist | 0.309 0.007 DBMET03018 0.875 0.002 DBMET00366 0.847 0.002 DBMET03023 0.788 0.002 DBMET03025 0.945 0.002 DBMET03029 0.688 0.003 DBMET03031 0.613 0.003 DBMET02136 0.785 0.002 DBMET03022 0.836 0.002 DBMET03024 0.727 0.003 DBMET03028 0.796 0.002 DBMET03030 0.553 0.003 DBMET03032 | DBMET03029 | |
| 0.872 | 0.002 | 0.957 | Estrogen agonist | 0.657 0.003 DBMET03018 0.866 0.002 DBMET00366 0.844 0.002 DBMET03023 0.837 0.002 DBMET03025 0.827 0.002 DBMET03029 0.957 0.001 DBMET03031 0.861 0.002 DBMET02136 0.784 0.002 DBMET03022 0.765 0.002 DBMET03024 0.759 0.002 DBMET03028 0.761 0.002 DBMET03030 0.93 0.001 DBMET03032 | DBMET03031 | |
| 0.811 | 0.001 | 0.838 | Androgen agonist | 0.316 0.003 DBMET03018 0.777 0.001 DBMET00366 0.712 0.001 DBMET03023 0.795 0.001 DBMET03025 0.838 0.001 DBMET03029 0.682 0.001 DBMET03031 0.768 0.001 DBMET02136 0.569 0.002 DBMET03022 0.608 0.002 DBMET03024 0.802 0.001 DBMET03028 0.665 0.001 DBMET03030 0.564 0.002 DBMET03032 | DBMET03029 | |
| 0.799 | 0.003 | 0.799 | Estrogen antagonist | 0.404 0.004 DBMET03018 0.766 0.003 DBMET00366 0.725 0.003 DBMET03023 0.733 0.003 DBMET03025 0.753 0.003 DBMET03029 0.634 0.003 DBMET03031 0.618 0.003 DBMET02136 0.648 0.003 DBMET03022 0.616 0.003 DBMET03024 0.641 0.003 DBMET03028 0.664 0.003 DBMET03030 0.541 0.004 DBMET03032 | ||
| 0.787 | 0.001 | 0.787 | Progesterone antagonist | 0.268 0.004 DBMET03018 0.778 0.001 DBMET00366 0.644 0.002 DBMET03023 0.781 0.001 DBMET03025 0.743 0.001 DBMET03029 0.586 0.002 DBMET03031 0.511 0.002 DBMET02136 0.739 0.001 DBMET03022 0.711 0.001 DBMET03024 0.713 0.001 DBMET03028 0.72 0.001 DBMET03030 0.581 0.002 DBMET03032 | ||
| 0.758 | 0.002 | 0.783 | Aromatase inhibitor | 0.166 0.011 DBMET03018 0.723 0.002 DBMET00366 0.754 0.002 DBMET03023 0.783 0.002 DBMET03025 0.712 0.002 DBMET03029 0.677 0.002 DBMET03031 0.681 0.002 DBMET02136 0.681 0.002 DBMET03022 0.719 0.002 DBMET03024 0.763 0.002 DBMET03028 0.654 0.002 DBMET03030 0.651 0.002 DBMET03032 | DBMET03025 | |
| 0.767 | 0.015 | 0.923 | Transcription factor NF kappa B inhibitor | 0.923 0.004 DBMET03018 0.773 0.015 DBMET00366 0.801 0.013 DBMET03023 0.832 0.011 DBMET03025 0.852 0.01 DBMET03029 0.782 0.014 DBMET03031 0.558 0.037 DBMET02136 0.806 0.012 DBMET03022 0.815 0.012 DBMET03024 0.853 0.01 DBMET03028 0.86 0.009 DBMET03030 0.715 0.019 DBMET03032 | DBMET03018 | |
| 0.758 | 0.021 | 0.846 | Antiinflammatory | 0.846 0.01 DBMET03018 0.79 0.017 DBMET00366 0.766 0.02 DBMET03023 0.791 0.017 DBMET03025 0.805 0.015 DBMET03029 0.727 0.026 DBMET03031 0.8 0.015 DBMET02136 0.739 0.024 DBMET03022 0.711 0.029 DBMET03024 0.756 0.022 DBMET03028 0.735 0.025 DBMET03030 0.7 0.031 DBMET03032 | DBMET03018 | |
| 0.737 | 0.004 | 0.784 | Hypoxia-inducible factor 1 alpha inhibitor | 0.755 0.004 DBMET03018 0.734 0.004 DBMET00366 0.76 0.004 DBMET03023 0.726 0.004 DBMET03025 0.784 0.003 DBMET03029 0.707 0.004 DBMET03031 0.475 0.017 DBMET02136 0.761 0.004 DBMET03022 0.778 0.003 DBMET03024 0.769 0.004 DBMET03028 0.735 0.004 DBMET03030 0.645 0.005 DBMET03032 | DBMET03029 | |
| 0.672 | 0.001 | 0.824 | Anabolic | 0.258 0.002 DBMET03018 0.599 0.001 DBMET00366 0.426 0.001 DBMET03023 0.634 0.001 DBMET03025 0.824 0.001 DBMET03029 0.565 0.001 DBMET03031 0.463 0.001 DBMET02136 0.338 0.001 DBMET03022 0.27 0.002 DBMET03024 0.353 0.001 DBMET03028 0.338 0.001 DBMET03030 0.333 0.001 DBMET03032 | DBMET03029 | |
| 0.681 | 0.026 | 0.775 | Caspase 9 stimulant | 0.641 0.031 DBMET03018 0.679 0.026 DBMET00366 0.644 0.03 DBMET03023 0.671 0.027 DBMET03025 0.671 0.027 DBMET03029 0.773 0.015 DBMET03031 0.305 0.188 DBMET02136 0.775 0.014 DBMET03022 0.738 0.019 DBMET03024 0.644 0.03 DBMET03028 0.523 0.052 DBMET03030 0.759 0.017 DBMET03032 | DBMET03022 | |
| 0.653 | 0.002 | 0.677 | Lipocortins synthesis antagonist | 0.56 0.003 DBMET03018 0.668 0.001 DBMET00366 0.639 0.002 DBMET03023 0.631 0.002 DBMET03025 0.677 0.001 DBMET03029 0.57 0.003 DBMET03031 0.613 0.002 DBMET02136 0.626 0.002 DBMET03022 0.608 0.002 DBMET03024 0.615 0.002 DBMET03028 0.625 0.002 DBMET03030 0.557 0.003 DBMET03032 | DBMET03029 | |
| 0.637 | 0.003 | 0.637 | Estrogen receptor beta antagonist | 0.195 0.01 DBMET03018 0.576 0.003 DBMET00366 0.547 0.003 DBMET03023 0.564 0.003 DBMET03025 0.592 0.003 DBMET03029 0.473 0.004 DBMET03031 0.448 0.004 DBMET02136 0.462 0.004 DBMET03022 0.444 0.004 DBMET03024 0.477 0.004 DBMET03028 0.509 0.004 DBMET03030 0.404 0.004 DBMET03032 | ||
| 0.67 | 0.036 | 0.717 | Apoptosis agonist | 0.716 0.028 DBMET03018 0.702 0.03 DBMET00366 0.717 0.028 DBMET03023 0.713 0.028 DBMET03025 0.714 0.028 DBMET03029 0.67 0.036 DBMET03031 0.59 0.051 DBMET02136 0.699 0.031 DBMET03022 0.702 0.03 DBMET03024 0.694 0.032 DBMET03028 0.698 0.031 DBMET03030 0.658 0.038 DBMET03032 | DBMET03023 | |
| 0.619 | 0.002 | 0.619 | Estradiol 17 beta-dehydrogenase inhibitor | 0.051 0.024 DBMET03018 0.544 0.002 DBMET00366 0.479 0.002 DBMET03023 0.448 0.002 DBMET03025 0.376 0.003 DBMET03029 0.543 0.002 DBMET03031 0.358 0.003 DBMET02136 0.506 0.002 DBMET03022 0.418 0.003 DBMET03024 0.399 0.003 DBMET03028 0.418 0.003 DBMET03030 0.49 0.002 DBMET03032 | ||
| 0.594 | 0.002 | 0.658 | Glucocorticoid antagonist | 0.284 0.003 DBMET03018 0.658 0.002 DBMET00366 0.559 0.002 DBMET03023 0.503 0.002 DBMET03025 0.57 0.002 DBMET03029 0.306 0.003 DBMET03031 0.448 0.002 DBMET02136 0.498 0.002 DBMET03022 0.488 0.002 DBMET03024 0.405 0.002 DBMET03028 0.426 0.002 DBMET03030 0.239 0.003 DBMET03032 | DBMET00366 | |
| 0.592 | 0.002 | 0.592 | Estrogen receptor alpha agonist | 0.31 0.003 DBMET03018 0.582 0.002 DBMET00366 0.556 0.002 DBMET03023 0.555 0.002 DBMET03025 0.56 0.002 DBMET03029 0.492 0.002 DBMET03031 0.526 0.002 DBMET02136 0.517 0.002 DBMET03022 0.501 0.002 DBMET03024 0.51 0.002 DBMET03028 0.517 0.002 DBMET03030 0.414 0.003 DBMET03032 | ||
| 0.589 | 0.002 | 0.589 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.559 0.002 DBMET00366 0.462 0.002 DBMET03023 0.52 0.002 DBMET03025 0.567 0.002 DBMET03029 0.511 0.002 DBMET03031 0.361 0.003 DBMET02136 0.495 0.002 DBMET03022 0.405 0.003 DBMET03024 0.387 0.003 DBMET03028 0.469 0.002 DBMET03030 0.378 0.003 DBMET03032 | ||
| 0.527 | 0.003 | 0.527 | Estrogen receptor beta agonist | 0.263 0.004 DBMET03018 0.495 0.003 DBMET00366 0.439 0.003 DBMET03023 0.458 0.003 DBMET03025 0.484 0.003 DBMET03029 0.422 0.003 DBMET03031 0.489 0.003 DBMET02136 0.371 0.003 DBMET03022 0.35 0.003 DBMET03024 0.364 0.003 DBMET03028 0.364 0.003 DBMET03030 0.332 0.004 DBMET03032 | ||
| 0.521 | 0.007 | 0.541 | Anesthetic general | 0.504 0.008 DBMET03018 0.535 0.006 DBMET00366 0.422 0.014 DBMET03023 0.501 0.008 DBMET03025 0.384 0.018 DBMET03029 0.541 0.006 DBMET03031 0.21 0.069 DBMET02136 0.525 0.006 DBMET03022 0.417 0.014 DBMET03024 0.49 0.009 DBMET03028 0.373 0.02 DBMET03030 0.53 0.006 DBMET03032 | DBMET03031 | |
| 0.512 | 0.003 | 0.566 | Sodium/bile acid cotransporter inhibitor | 0.46 0.006 DBMET03018 0.514 0.003 DBMET00366 0.501 0.004 DBMET03023 0.52 0.003 DBMET03025 0.566 0.002 DBMET03029 0.489 0.004 DBMET03031 0.483 0.005 DBMET02136 0.498 0.004 DBMET03022 0.497 0.004 DBMET03024 0.504 0.004 DBMET03028 0.521 0.003 DBMET03030 0.473 0.005 DBMET03032 | DBMET03029 | |
| 0.502 | 0.032 | 0.567 | Immunosuppressant | 0.567 0.018 DBMET03018 0.518 0.028 DBMET00366 0.513 0.03 DBMET03023 0.52 0.028 DBMET03025 0.543 0.022 DBMET03029 0.498 0.034 DBMET03031 0.478 0.039 DBMET02136 0.489 0.036 DBMET03022 0.493 0.035 DBMET03024 0.536 0.024 DBMET03028 0.539 0.023 DBMET03030 0.529 0.026 DBMET03032 | DBMET03018 | |
| 0.468 | 0.009 | 0.669 | Diuretic | 0.669 0.004 DBMET03018 0.503 0.007 DBMET00366 0.362 0.015 DBMET03023 0.362 0.015 DBMET03025 0.314 0.02 DBMET03029 0.353 0.016 DBMET03031 0.588 0.005 DBMET02136 0.354 0.016 DBMET03022 0.244 0.032 DBMET03024 0.293 0.024 DBMET03028 0.203 0.043 DBMET03030 0.276 0.027 DBMET03032 | DBMET03018 | |
| 0.44 | 0.002 | 0.457 | Prolactin inhibitor | 0.098 0.057 DBMET03018 0.42 0.002 DBMET00366 0.457 0.001 DBMET03023 0.302 0.003 DBMET03025 0.302 0.003 DBMET03029 0.327 0.003 DBMET03031 0.269 0.004 DBMET02136 0.351 0.002 DBMET03022 0.365 0.002 DBMET03024 0.272 0.004 DBMET03028 0.271 0.004 DBMET03030 0.295 0.003 DBMET03032 | DBMET03023 | |
| 0.415 | 0.001 | 0.452 | Progesterone agonist | 0.194 0.002 DBMET03018 0.452 0.001 DBMET00366 0.385 0.001 DBMET03023 0.356 0.001 DBMET03025 0.326 0.002 DBMET03029 0.237 0.002 DBMET03031 0.322 0.002 DBMET02136 0.338 0.001 DBMET03022 0.312 0.002 DBMET03024 0.29 0.002 DBMET03028 0.252 0.002 DBMET03030 0.192 0.002 DBMET03032 | DBMET00366 | |
| 0.392 | 0.003 | 0.424 | Mineralocorticoid receptor antagonist | 0.118 0.006 DBMET03018 0.424 0.003 DBMET00366 0.342 0.004 DBMET03023 0.317 0.004 DBMET03025 0.304 0.004 DBMET03029 0.201 0.004 DBMET03031 0.26 0.004 DBMET02136 0.323 0.004 DBMET03022 0.305 0.004 DBMET03024 0.241 0.004 DBMET03028 0.221 0.004 DBMET03030 0.162 0.005 DBMET03032 | DBMET00366 | |
| 0.379 | 0.002 | 0.379 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.323 0.002 DBMET00366 0.195 0.003 DBMET03023 0.188 0.003 DBMET03025 0.13 0.004 DBMET03029 0.265 0.003 DBMET03031 0.101 0.004 DBMET02136 0.294 0.002 DBMET03022 0.192 0.003 DBMET03024 0.224 0.003 DBMET03028 0.146 0.004 DBMET03030 0.304 0.002 DBMET03032 | ||
| 0.399 | 0.029 | 0.451 | DNA damaging | 0.426 0.023 DBMET03018 0.415 0.025 DBMET00366 0.439 0.021 DBMET03023 0.383 0.032 DBMET03025 0.425 0.023 DBMET03029 0.393 0.03 DBMET03031 0.221 0.1 DBMET02136 0.451 0.019 DBMET03022 0.43 0.022 DBMET03024 0.385 0.032 DBMET03028 0.417 0.025 DBMET03030 0.394 0.03 DBMET03032 | DBMET03022 | |
| 0.378 | 0.011 | 0.431 | Lipid peroxidase inhibitor | 0.42 0.009 DBMET03018 0.431 0.008 DBMET00366 0.42 0.009 DBMET03023 0.324 0.016 DBMET03025 0.353 0.013 DBMET03029 0.252 0.026 DBMET03031 0.261 0.025 DBMET02136 0.386 0.01 DBMET03022 0.39 0.01 DBMET03024 0.268 0.024 DBMET03028 0.311 0.017 DBMET03030 0.221 0.034 DBMET03032 | DBMET00366 | |
| 0.371 | 0.007 | 0.382 | Neurotrophic factor enhancer | 0.382 0.007 DBMET03018 0.37 0.007 DBMET00366 0.34 0.01 DBMET03023 0.327 0.012 DBMET03025 0.344 0.01 DBMET03029 0.354 0.009 DBMET03031 0.192 0.084 DBMET02136 0.346 0.01 DBMET03022 0.276 0.026 DBMET03024 0.28 0.024 DBMET03028 0.339 0.01 DBMET03030 0.301 0.018 DBMET03032 | DBMET03018 | |
| 0.366 | 0.01 | 0.418 | NOS3 expression enhancer | 0.418 0.007 DBMET03018 0.375 0.009 DBMET00366 0.311 0.016 DBMET03023 0.311 0.016 DBMET03025 0.312 0.016 DBMET03029 0.381 0.009 DBMET03031 0.187 0.046 DBMET02136 0.32 0.015 DBMET03022 0.265 0.023 DBMET03024 0.267 0.023 DBMET03028 0.317 0.015 DBMET03030 0.338 0.013 DBMET03032 | DBMET03018 | |
| 0.339 | 0.004 | 0.378 | Keratolytic | 0.082 0.046 DBMET03018 0.33 0.004 DBMET00366 0.264 0.005 DBMET03023 0.341 0.004 DBMET03025 0.213 0.007 DBMET03029 0.378 0.003 DBMET03031 0.113 0.024 DBMET02136 0.343 0.004 DBMET03022 0.263 0.005 DBMET03024 0.291 0.004 DBMET03028 0.177 0.011 DBMET03030 0.319 0.004 DBMET03032 | DBMET03031 | |
| 0.332 | 0.003 | 0.367 | Aldosterone antagonist | 0.065 0.017 DBMET03018 0.367 0.002 DBMET00366 0.22 0.004 DBMET03023 0.196 0.004 DBMET03025 0.225 0.004 DBMET03029 0.218 0.004 DBMET03031 0.226 0.004 DBMET02136 0.263 0.003 DBMET03022 0.183 0.004 DBMET03024 0.146 0.005 DBMET03028 0.115 0.007 DBMET03030 0.164 0.005 DBMET03032 | DBMET00366 | |
| 0.359 | 0.03 | 0.485 | Nitric oxide antagonist | 0.485 0.017 DBMET03018 0.392 0.026 DBMET00366 0.398 0.026 DBMET03023 0.429 0.022 DBMET03025 0.425 0.023 DBMET03029 0.423 0.023 DBMET03031 0.346 0.032 DBMET02136 0.379 0.028 DBMET03022 0.369 0.029 DBMET03024 0.418 0.024 DBMET03028 0.403 0.025 DBMET03030 0.414 0.024 DBMET03032 | DBMET03018 | |
| 0.315 | 0.016 | 0.613 | Monophenol monooxygenase inhibitor | 0.613 0.005 DBMET03018 0.299 0.018 DBMET00366 0.357 0.013 DBMET03023 0.281 0.02 DBMET03025 0.324 0.015 DBMET03029 0.201 0.033 DBMET03031 0.143 0.05 DBMET02136 0.323 0.016 DBMET03022 0.362 0.013 DBMET03024 0.24 0.025 DBMET03028 0.217 0.029 DBMET03030 0.167 0.041 DBMET03032 | DBMET03018 | |
| 0.311 | 0.016 | 0.311 | Bone formation stimulant | 0.227 0.029 DBMET03018 0.304 0.017 DBMET00366 0.286 0.019 DBMET03023 0.215 0.032 DBMET03025 0.233 0.028 DBMET03029 0.198 0.036 DBMET03031 0.253 0.024 DBMET02136 0.272 0.021 DBMET03022 0.234 0.028 DBMET03024 0.227 0.029 DBMET03028 0.222 0.03 DBMET03030 0.18 0.042 DBMET03032 | ||
| 0.354 | 0.063 | 0.638 | Cholesterol antagonist | 0.638 0.014 DBMET03018 0.359 0.061 DBMET00366 0.325 0.076 DBMET03023 0.417 0.046 DBMET03025 0.533 0.028 DBMET03029 0.406 0.048 DBMET03031 0.288 0.099 DBMET02136 0.335 0.071 DBMET03022 0.304 0.089 DBMET03024 0.398 0.05 DBMET03028 0.4 0.049 DBMET03030 0.388 0.052 DBMET03032 | DBMET03018 | |
| 0.305 | 0.019 | 0.481 | Interferon gamma antagonist | 0.481 0.007 DBMET03018 0.316 0.018 DBMET00366 0.311 0.018 DBMET03023 0.305 0.019 DBMET03025 0.343 0.015 DBMET03029 0.286 0.022 DBMET03031 0.153 0.074 DBMET02136 0.302 0.02 DBMET03022 0.26 0.027 DBMET03024 0.306 0.019 DBMET03028 0.302 0.02 DBMET03030 0.287 0.022 DBMET03032 | DBMET03018 | |
| 0.295 | 0.015 | 0.295 | Antipruritic | 0.197 0.051 DBMET03018 0.283 0.017 DBMET00366 0.232 0.031 DBMET03023 0.222 0.036 DBMET03025 0.287 0.016 DBMET03029 0.233 0.031 DBMET03031 0.134 0.115 DBMET02136 0.225 0.034 DBMET03022 0.234 0.03 DBMET03024 0.193 0.054 DBMET03028 0.214 0.04 DBMET03030 0.141 0.106 DBMET03032 | ||
| 0.284 | 0.003 | 0.29 | 5-Alpha-reductase inhibitor | 0.178 0.006 DBMET03018 0.289 0.003 DBMET00366 0.247 0.004 DBMET03023 0.214 0.004 DBMET03025 0.29 0.003 DBMET03029 0.193 0.005 DBMET03031 0.099 0.01 DBMET02136 0.22 0.004 DBMET03022 0.205 0.005 DBMET03024 0.176 0.006 DBMET03028 0.231 0.004 DBMET03030 0.147 0.007 DBMET03032 | DBMET03029 | |
| 0.278 | 0.003 | 0.285 | Arachidonic acid antagonist | 0.241 0.008 DBMET03018 0.285 0.002 DBMET00366 0.271 0.003 DBMET03023 0.281 0.003 DBMET03025 0.275 0.003 DBMET03029 0.282 0.003 DBMET03031 0.245 0.007 DBMET02136 0.272 0.003 DBMET03022 0.272 0.003 DBMET03024 0.272 0.003 DBMET03028 0.255 0.005 DBMET03030 0.262 0.004 DBMET03032 | DBMET00366 | |
| 0.308 | 0.059 | 0.554 | Antioxidant | 0.554 0.015 DBMET03018 0.35 0.046 DBMET00366 0.384 0.038 DBMET03023 0.345 0.048 DBMET03025 0.363 0.043 DBMET03029 0.349 0.047 DBMET03031 0.315 0.056 DBMET02136 0.357 0.044 DBMET03022 0.349 0.047 DBMET03024 0.307 0.059 DBMET03028 0.333 0.051 DBMET03030 0.343 0.048 DBMET03032 | DBMET03018 | |
| 0.25 | 0.003 | 0.25 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.188 0.004 DBMET00366 0.124 0.007 DBMET03023 0.124 0.007 DBMET03025 0.152 0.005 DBMET03029 0.208 0.004 DBMET03031 0.148 0.005 DBMET02136 0.129 0.006 DBMET03022 0.094 0.011 DBMET03024 0.089 0.013 DBMET03028 0.107 0.009 DBMET03030 0.149 0.005 DBMET03032 | ||
| 0.293 | 0.046 | 0.455 | DNA synthesis inhibitor | 0.455 0.017 DBMET03018 0.3 0.044 DBMET00366 0.294 0.045 DBMET03023 0.331 0.034 DBMET03025 0.3 0.044 DBMET03029 0.317 0.038 DBMET03031 0.187 0.143 DBMET02136 0.248 0.068 DBMET03022 0.236 0.077 DBMET03024 0.297 0.044 DBMET03028 0.275 0.053 DBMET03030 0.283 0.05 DBMET03032 | DBMET03018 | |
| 0.259 | 0.023 | 0.266 | Acetylcholine M1 receptor antagonist | 0.266 0.021 DBMET00366 0.254 0.024 DBMET03023 0.224 0.033 DBMET03025 0.206 0.04 DBMET03029 0.208 0.039 DBMET03031 0.128 0.098 DBMET02136 0.211 0.038 DBMET03022 0.202 0.041 DBMET03024 0.221 0.034 DBMET03028 0.165 0.062 DBMET03030 0.173 0.056 DBMET03032 | DBMET00366 | |
| 0.262 | 0.038 | 0.536 | Non-steroidal antiinflammatory agent | 0.536 0.005 DBMET03018 0.264 0.038 DBMET00366 0.232 0.051 DBMET03023 0.191 0.078 DBMET03025 0.228 0.053 DBMET03029 0.157 0.107 DBMET03031 0.15 0.115 DBMET02136 0.304 0.027 DBMET03022 0.234 0.05 DBMET03024 0.212 0.062 DBMET03028 0.27 0.035 DBMET03030 0.182 0.085 DBMET03032 | DBMET03018 | |
| 0.258 | 0.039 | 0.289 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.183 0.089 DBMET03018 0.255 0.04 DBMET00366 0.28 0.03 DBMET03023 0.273 0.033 DBMET03025 0.289 0.027 DBMET03029 0.243 0.046 DBMET03031 0.261 0.038 DBMET03022 0.275 0.032 DBMET03024 0.227 0.054 DBMET03028 0.198 0.074 DBMET03030 0.198 0.074 DBMET03032 | DBMET03029 | |
| 0.213 | 0.002 | 0.25 | Estrone sulfatase inhibitor | 0.151 0.003 DBMET03018 0.216 0.002 DBMET00366 0.206 0.002 DBMET03023 0.189 0.002 DBMET03025 0.181 0.002 DBMET03029 0.18 0.002 DBMET03031 0.25 0.001 DBMET02136 0.193 0.002 DBMET03022 0.188 0.002 DBMET03024 0.174 0.003 DBMET03028 0.169 0.003 DBMET03030 0.169 0.003 DBMET03032 | DBMET02136 | |
| 0.23 | 0.025 | 0.251 | Cholinergic antagonist | 0.224 0.026 DBMET00366 0.182 0.037 DBMET03023 0.251 0.021 DBMET03025 0.181 0.037 DBMET03029 0.201 0.032 DBMET03031 0.106 0.088 DBMET02136 0.174 0.04 DBMET03022 0.16 0.047 DBMET03024 0.249 0.021 DBMET03028 0.194 0.034 DBMET03030 0.185 0.036 DBMET03032 | DBMET03025 | |
| 0.32 | 0.118 | 0.356 | 15-Lipoxygenase inhibitor | 0.336 0.108 DBMET00366 0.341 0.104 DBMET03023 0.243 0.17 DBMET03029 0.356 0.096 DBMET03022 0.318 0.119 DBMET03024 0.259 0.157 DBMET03030 | DBMET03022 | |
| 0.226 | 0.025 | 0.246 | Acetylcholine antagonist | 0.219 0.026 DBMET00366 0.179 0.037 DBMET03023 0.228 0.024 DBMET03025 0.176 0.038 DBMET03029 0.198 0.031 DBMET03031 0.104 0.087 DBMET02136 0.171 0.04 DBMET03022 0.157 0.047 DBMET03024 0.246 0.021 DBMET03028 0.189 0.034 DBMET03030 0.183 0.035 DBMET03032 | DBMET03028 | |
| 0.284 | 0.087 | 0.418 | Caspase 3 stimulant | 0.316 0.071 DBMET03018 0.292 0.083 DBMET00366 0.252 0.111 DBMET03023 0.418 0.039 DBMET03025 0.359 0.056 DBMET03029 0.34 0.062 DBMET03031 0.366 0.054 DBMET03022 0.35 0.059 DBMET03024 0.346 0.06 DBMET03028 0.308 0.075 DBMET03030 0.346 0.06 DBMET03032 | DBMET03025 | |
| 0.215 | 0.023 | 0.295 | Cholesterol synthesis inhibitor | 0.154 0.042 DBMET03018 0.223 0.022 DBMET00366 0.188 0.03 DBMET03023 0.244 0.019 DBMET03025 0.295 0.012 DBMET03029 0.253 0.017 DBMET03031 0.211 0.024 DBMET02136 0.239 0.019 DBMET03022 0.242 0.019 DBMET03024 0.202 0.026 DBMET03028 0.264 0.016 DBMET03030 0.21 0.024 DBMET03032 | DBMET03029 | |
| 0.238 | 0.047 | 0.437 | Hepatoprotectant | 0.437 0.01 DBMET03018 0.265 0.039 DBMET00366 0.283 0.034 DBMET03023 0.312 0.026 DBMET03025 0.346 0.019 DBMET03029 0.307 0.028 DBMET03031 0.231 0.05 DBMET02136 0.265 0.039 DBMET03022 0.28 0.036 DBMET03024 0.278 0.036 DBMET03028 0.317 0.025 DBMET03030 0.257 0.041 DBMET03032 | DBMET03018 | |
| 0.19 | 0.003 | 0.212 | RNA-directed RNA polymerase stimulant | 0.109 0.005 DBMET03018 0.212 0.003 DBMET00366 0.182 0.003 DBMET03023 0.181 0.003 DBMET03025 0.163 0.004 DBMET03029 0.166 0.004 DBMET03031 0.147 0.004 DBMET02136 0.167 0.004 DBMET03022 0.152 0.004 DBMET03024 0.148 0.004 DBMET03028 0.133 0.004 DBMET03030 0.135 0.004 DBMET03032 | DBMET00366 | |
| 0.233 | 0.047 | 0.323 | P-glycoprotein inhibitor | 0.221 0.053 DBMET03018 0.242 0.044 DBMET00366 0.256 0.039 DBMET03023 0.277 0.034 DBMET03025 0.294 0.03 DBMET03029 0.219 0.053 DBMET03031 0.149 0.119 DBMET02136 0.292 0.03 DBMET03022 0.289 0.031 DBMET03024 0.31 0.027 DBMET03028 0.323 0.025 DBMET03030 0.238 0.045 DBMET03032 | DBMET03030 | |
| 0.196 | 0.019 | 0.238 | Alpha 2c adrenoreceptor antagonist | 0.2 0.018 DBMET00366 0.226 0.013 DBMET03023 0.097 0.069 DBMET03031 0.238 0.012 DBMET03022 0.238 0.012 DBMET03024 0.093 0.073 DBMET03028 0.088 0.078 DBMET03030 0.112 0.055 DBMET03032 | DBMET03024 | |
| 0.195 | 0.023 | 0.264 | Farnesoid X receptor antagonist | 0.123 0.096 DBMET03018 0.188 0.026 DBMET00366 0.166 0.038 DBMET03023 0.206 0.02 DBMET03025 0.264 0.009 DBMET03029 0.21 0.019 DBMET03031 0.122 0.098 DBMET02136 0.169 0.035 DBMET03022 0.158 0.044 DBMET03024 0.182 0.028 DBMET03028 0.197 0.023 DBMET03030 0.185 0.027 DBMET03032 | DBMET03029 | |
| 0.182 | 0.017 | 0.208 | Pregnane X receptor agonist | 0.186 0.016 DBMET00366 0.161 0.036 DBMET03023 0.194 0.012 DBMET03025 0.147 0.058 DBMET03029 0.2 0.01 DBMET03031 0.208 0.009 DBMET02136 0.166 0.03 DBMET03022 0.149 0.054 DBMET03024 0.168 0.028 DBMET03028 0.144 0.065 DBMET03030 0.195 0.012 DBMET03032 | DBMET02136 | |
| 0.179 | 0.019 | 0.186 | Interleukin 8 antagonist | 0.186 0.017 DBMET00366 0.179 0.02 DBMET03023 0.124 0.056 DBMET03025 0.143 0.039 DBMET03029 0.121 0.06 DBMET03031 0.152 0.033 DBMET03022 0.132 0.048 DBMET03024 | DBMET00366 | |
| 0.179 | 0.02 | 0.202 | Antineoplastic alkaloid | 0.077 0.069 DBMET03018 0.188 0.017 DBMET00366 0.148 0.028 DBMET03023 0.174 0.021 DBMET03025 0.202 0.013 DBMET03029 0.191 0.016 DBMET03031 0.081 0.064 DBMET02136 0.183 0.019 DBMET03022 0.181 0.019 DBMET03024 0.171 0.022 DBMET03028 0.169 0.022 DBMET03030 0.188 0.017 DBMET03032 | DBMET03029 | |
| 0.159 | 0.006 | 0.179 | Glycine receptor agonist | 0.138 0.009 DBMET03018 0.179 0.005 DBMET00366 0.143 0.008 DBMET03023 0.139 0.008 DBMET03025 0.158 0.006 DBMET03029 0.173 0.005 DBMET03031 0.082 0.036 DBMET02136 0.152 0.007 DBMET03022 0.138 0.009 DBMET03024 0.139 0.008 DBMET03028 0.158 0.006 DBMET03030 0.173 0.005 DBMET03032 | DBMET00366 | |
| 0.169 | 0.016 | 0.2 | Acetylcholine nicotinic antagonist | 0.166 0.017 DBMET00366 0.132 0.026 DBMET03023 0.165 0.017 DBMET03025 0.097 0.041 DBMET03029 0.153 0.019 DBMET03031 0.071 0.067 DBMET02136 0.142 0.023 DBMET03022 0.134 0.025 DBMET03024 0.2 0.013 DBMET03028 0.126 0.028 DBMET03030 0.152 0.02 DBMET03032 | DBMET03028 | |
| 0.196 | 0.043 | 0.258 | Interleukin 6 antagonist | 0.257 0.022 DBMET03018 0.206 0.037 DBMET00366 0.217 0.032 DBMET03023 0.258 0.021 DBMET03025 0.188 0.048 DBMET03029 0.169 0.065 DBMET03031 0.198 0.042 DBMET03022 0.179 0.055 DBMET03024 0.197 0.043 DBMET03028 0.182 0.053 DBMET03030 0.158 0.077 DBMET03032 | DBMET03025 | |
| 0.155 | 0.009 | 0.244 | Alpha tubulin antagonist | 0.183 0.007 DBMET00366 0.153 0.009 DBMET03023 0.173 0.008 DBMET03025 0.086 0.018 DBMET03029 0.126 0.012 DBMET03031 0.101 0.015 DBMET02136 0.236 0.005 DBMET03022 0.244 0.005 DBMET03024 0.242 0.005 DBMET03028 0.099 0.015 DBMET03030 0.138 0.011 DBMET03032 | DBMET03024 | |
| 0.143 | 0.003 | 0.143 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.1 0.004 DBMET00366 0.064 0.005 DBMET03023 0.052 0.007 DBMET03025 0.06 0.005 DBMET03029 0.12 0.004 DBMET03031 0.055 0.006 DBMET02136 0.072 0.005 DBMET03022 0.049 0.007 DBMET03024 0.028 0.013 DBMET03028 0.052 0.006 DBMET03030 0.072 0.005 DBMET03032 | ||
| 0.15 | 0.012 | 0.247 | Beta tubulin antagonist | 0.178 0.009 DBMET00366 0.147 0.012 DBMET03023 0.145 0.013 DBMET03025 0.074 0.032 DBMET03029 0.123 0.017 DBMET03031 0.076 0.031 DBMET02136 0.241 0.005 DBMET03022 0.247 0.005 DBMET03024 0.182 0.009 DBMET03028 0.087 0.027 DBMET03030 0.132 0.015 DBMET03032 | DBMET03024 | |
| 0.173 | 0.036 | 0.34 | Alkylator | 0.34 0.01 DBMET03018 0.178 0.033 DBMET00366 0.189 0.029 DBMET03023 0.242 0.018 DBMET03025 0.22 0.021 DBMET03029 0.176 0.035 DBMET03031 0.13 0.059 DBMET02136 0.186 0.031 DBMET03022 0.169 0.038 DBMET03024 0.233 0.019 DBMET03028 0.209 0.024 DBMET03030 0.171 0.037 DBMET03032 | DBMET03018 | |
| 0.258 | 0.12 | 0.41 | Apoptosis antagonist | 0.41 0.035 DBMET03018 0.278 0.101 DBMET00366 0.277 0.103 DBMET03023 0.316 0.075 DBMET03025 0.376 0.045 DBMET03029 0.287 0.095 DBMET03031 0.28 0.1 DBMET03022 0.286 0.096 DBMET03024 0.269 0.109 DBMET03028 0.34 0.061 DBMET03030 0.27 0.108 DBMET03032 | DBMET03018 | |
| 0.146 | 0.01 | 0.201 | Adrenaline uptake inhibitor | 0.055 0.05 DBMET03018 0.148 0.009 DBMET00366 0.126 0.013 DBMET03023 0.201 0.006 DBMET03025 0.126 0.013 DBMET03029 0.1 0.019 DBMET03031 0.077 0.029 DBMET02136 0.119 0.014 DBMET03022 0.105 0.017 DBMET03024 0.14 0.01 DBMET03028 0.114 0.015 DBMET03030 0.076 0.029 DBMET03032 | DBMET03025 | |
| 0.143 | 0.009 | 0.201 | Glycine receptor antagonist | 0.201 0.004 DBMET03018 0.15 0.007 DBMET00366 0.121 0.017 DBMET03023 0.149 0.008 DBMET03025 0.162 0.005 DBMET03029 0.172 0.005 DBMET03031 0.149 0.008 DBMET02136 0.125 0.016 DBMET03022 0.119 0.019 DBMET03024 0.133 0.012 DBMET03028 0.127 0.015 DBMET03030 0.155 0.006 DBMET03032 | DBMET03018 | |
| 0.135 | 0.005 | 0.135 | Estrogen-related receptor beta agonist | 0.119 0.01 DBMET00366 0.106 0.019 DBMET03023 0.108 0.017 DBMET03025 0.104 0.02 DBMET03029 0.124 0.008 DBMET03031 0.081 0.063 DBMET02136 0.114 0.013 DBMET03022 0.101 0.023 DBMET03024 0.099 0.025 DBMET03028 0.096 0.03 DBMET03030 0.114 0.013 DBMET03032 | ||
| 0.129 | 0.003 | 0.135 | Lipocortins synthesis agonist | 0.117 0.003 DBMET03018 0.133 0.002 DBMET00366 0.126 0.003 DBMET03023 0.127 0.003 DBMET03025 0.135 0.002 DBMET03029 0.118 0.003 DBMET03031 0.118 0.003 DBMET02136 0.122 0.003 DBMET03022 0.119 0.003 DBMET03024 0.12 0.003 DBMET03028 0.116 0.003 DBMET03030 0.111 0.004 DBMET03032 | DBMET03029 | |
| 0.126 | 0.002 | 0.144 | Glucocorticoid agonist | 0.059 0.004 DBMET03018 0.144 0.002 DBMET00366 0.118 0.003 DBMET03023 0.105 0.003 DBMET03025 0.129 0.002 DBMET03029 0.089 0.003 DBMET03031 0.089 0.003 DBMET02136 0.103 0.003 DBMET03022 0.105 0.003 DBMET03024 0.079 0.003 DBMET03028 0.073 0.003 DBMET03030 0.068 0.003 DBMET03032 | DBMET00366 | |
| 0.17 | 0.049 | 0.351 | Tubulin antagonist | 0.198 0.037 DBMET00366 0.208 0.035 DBMET03023 0.162 0.053 DBMET03025 0.139 0.064 DBMET03031 0.104 0.097 DBMET02136 0.326 0.017 DBMET03022 0.351 0.014 DBMET03024 0.256 0.024 DBMET03028 0.141 0.062 DBMET03030 0.196 0.038 DBMET03032 | DBMET03024 | |
| 0.175 | 0.055 | 0.308 | Melanin inhibitor | 0.308 0.021 DBMET03018 0.17 0.059 DBMET00366 0.154 0.076 DBMET03023 0.162 0.067 DBMET03025 0.19 0.046 DBMET03029 0.162 0.067 DBMET03031 0.187 0.047 DBMET03022 0.17 0.059 DBMET03024 0.176 0.054 DBMET03028 0.211 0.037 DBMET03030 0.176 0.054 DBMET03032 | DBMET03018 | |
| 0.243 | 0.127 | 0.396 | Interleukin 2 agonist | 0.396 0.029 DBMET03018 0.232 0.14 DBMET00366 0.216 0.163 DBMET03023 0.271 0.097 DBMET03025 0.296 0.076 DBMET03029 0.271 0.097 DBMET03031 0.254 0.114 DBMET03028 0.278 0.091 DBMET03030 0.254 0.114 DBMET03032 | DBMET03018 | |
| 0.155 | 0.041 | 0.155 | Acetylcholine muscarinic antagonist | 0.151 0.043 DBMET00366 0.133 0.056 DBMET03023 0.155 0.041 DBMET03025 0.137 0.053 DBMET03029 0.138 0.052 DBMET03031 0.121 0.066 DBMET03022 0.109 0.08 DBMET03024 0.154 0.041 DBMET03028 0.135 0.054 DBMET03030 0.124 0.063 DBMET03032 | ||
| 0.149 | 0.038 | 0.235 | Microtubule formation inhibitor | 0.202 0.019 DBMET03018 0.174 0.027 DBMET00366 0.157 0.034 DBMET03023 0.201 0.019 DBMET03025 0.194 0.021 DBMET03029 0.198 0.02 DBMET03031 0.103 0.085 DBMET02136 0.19 0.022 DBMET03022 0.186 0.023 DBMET03024 0.235 0.013 DBMET03028 0.179 0.025 DBMET03030 0.205 0.019 DBMET03032 | DBMET03028 | |
| 0.159 | 0.049 | 0.184 | Adenylate cyclase stimulant | 0.174 0.031 DBMET00366 0.144 0.073 DBMET03023 0.162 0.045 DBMET03025 0.177 0.029 DBMET03029 0.184 0.023 DBMET03031 0.161 0.046 DBMET02136 0.158 0.051 DBMET03022 0.128 0.107 DBMET03024 0.133 0.095 DBMET03028 0.131 0.098 DBMET03030 0.155 0.055 DBMET03032 | DBMET03031 | |
| 0.127 | 0.021 | 0.127 | Opioid kappa receptor antagonist | 0.102 0.034 DBMET00366 0.08 0.058 DBMET03023 0.08 0.058 DBMET03025 0.096 0.039 DBMET03029 0.093 0.043 DBMET03031 0.085 0.052 DBMET03022 0.081 0.056 DBMET03028 0.089 0.046 DBMET03030 0.086 0.05 DBMET03032 | ||
| 0.106 | 0.001 | 0.112 | Progesterone receptor A antagonist | 0.112 0.001 DBMET00366 0.076 0.002 DBMET03023 0.048 0.002 DBMET03025 0.041 0.002 DBMET03029 0.034 0.003 DBMET03031 0.035 0.003 DBMET02136 0.107 0.001 DBMET03022 0.086 0.001 DBMET03024 0.053 0.002 DBMET03028 0.046 0.002 DBMET03030 0.038 0.002 DBMET03032 | DBMET00366 | |
| 0.128 | 0.023 | 0.128 | Macrophage migration inhibitory factor inhibitor | 0.107 0.031 DBMET00366 0.084 0.046 DBMET03023 0.097 0.036 DBMET03025 0.072 0.063 DBMET03029 0.12 0.026 DBMET03022 0.097 0.036 DBMET03024 0.092 0.04 DBMET03028 0.069 0.068 DBMET03030 | ||
| 0.106 | 0.004 | 0.106 | 5-Alpha-reductase 1 inhibitor | 0.101 0.005 DBMET00366 0.089 0.005 DBMET03023 0.016 0.012 DBMET03025 0.023 0.01 DBMET03029 0.043 0.007 DBMET03031 0.036 0.008 DBMET03022 0.024 0.01 DBMET03024 | ||
| 0.115 | 0.019 | 0.134 | Na+ K+ transporting ATPase inhibitor | 0.134 0.01 DBMET03018 0.119 0.017 DBMET00366 0.117 0.018 DBMET03023 0.122 0.015 DBMET03025 0.126 0.013 DBMET03029 0.127 0.013 DBMET03031 0.112 0.021 DBMET02136 0.109 0.024 DBMET03022 0.108 0.025 DBMET03024 0.117 0.018 DBMET03028 0.121 0.016 DBMET03030 0.122 0.015 DBMET03032 | DBMET03018 | |
| 0.184 | 0.09 | 0.191 | Psychostimulant | 0.191 0.085 DBMET03018 0.185 0.089 DBMET00366 0.164 0.105 DBMET03023 0.152 0.114 DBMET03031 0.165 0.104 DBMET03022 0.158 0.109 DBMET03024 | DBMET03018 | |
| 0.145 | 0.052 | 0.182 | DNA polymerase I inhibitor | 0.163 0.042 DBMET03018 0.173 0.038 DBMET00366 0.152 0.048 DBMET03023 0.178 0.036 DBMET03025 0.182 0.034 DBMET03029 0.15 0.049 DBMET03031 0.159 0.044 DBMET03022 0.139 0.055 DBMET03024 0.15 0.049 DBMET03028 0.154 0.047 DBMET03030 0.122 0.067 DBMET03032 | DBMET03029 | |
| 0.112 | 0.028 | 0.127 | Bile acid receptor antagonist | 0.111 0.03 DBMET00366 0.097 0.056 DBMET03023 0.114 0.026 DBMET03025 0.125 0.016 DBMET03029 0.127 0.014 DBMET03031 0.097 0.056 DBMET02136 0.102 0.045 DBMET03022 0.093 0.066 DBMET03024 0.106 0.037 DBMET03028 0.103 0.043 DBMET03030 0.118 0.021 DBMET03032 | DBMET03031 | |
| 0.087 | 0.005 | 0.087 | 5-Alpha-reductase 2 inhibitor | 0.083 0.005 DBMET00366 0.073 0.006 DBMET03023 0.02 0.013 DBMET03025 0.022 0.011 DBMET03029 0.035 0.008 DBMET03031 0.026 0.01 DBMET03022 0.021 0.012 DBMET03024 | ||
| 0.081 | 0.003 | 0.081 | Estrogen-related receptor beta antagonist | 0.034 0.02 DBMET03018 0.067 0.004 DBMET00366 0.058 0.004 DBMET03023 0.066 0.004 DBMET03025 0.064 0.004 DBMET03029 0.07 0.004 DBMET03031 0.048 0.006 DBMET02136 0.056 0.005 DBMET03022 0.052 0.005 DBMET03024 0.059 0.004 DBMET03028 0.057 0.004 DBMET03030 0.062 0.004 DBMET03032 | ||
| 0.11 | 0.034 | 0.119 | Ornithine decarboxylase inhibitor | 0.088 0.058 DBMET03018 0.119 0.026 DBMET00366 0.115 0.03 DBMET03023 0.108 0.036 DBMET03025 0.087 0.059 DBMET03029 0.087 0.059 DBMET03031 0.075 0.074 DBMET02136 0.108 0.036 DBMET03022 0.117 0.028 DBMET03024 0.113 0.032 DBMET03028 | DBMET00366 | |
| 0.087 | 0.011 | 0.094 | Heme oxygenase stimulant | 0.07 0.026 DBMET03018 0.088 0.011 DBMET00366 0.094 0.009 DBMET03023 0.076 0.019 DBMET03025 0.076 0.019 DBMET03029 0.079 0.016 DBMET03031 0.075 0.019 DBMET02136 0.08 0.015 DBMET03022 0.087 0.011 DBMET03024 0.073 0.022 DBMET03028 0.073 0.022 DBMET03030 0.075 0.019 DBMET03032 | DBMET03023 | |
| 0.126 | 0.052 | 0.129 | GABA receptor agonist | 0.129 0.049 DBMET00366 0.111 0.065 DBMET03022 | DBMET00366 | |
| 0.098 | 0.027 | 0.127 | 5 Hydroxytryptamine uptake inhibitor | 0.094 0.028 DBMET00366 0.082 0.033 DBMET03023 0.127 0.019 DBMET03025 0.066 0.041 DBMET03029 0.057 0.049 DBMET03031 0.07 0.039 DBMET03022 0.072 0.037 DBMET03024 0.076 0.035 DBMET03028 0.06 0.046 DBMET03030 | DBMET03025 | |
| 0.086 | 0.019 | 0.09 | GABA receptor antagonist | 0.079 0.022 DBMET00366 0.066 0.028 DBMET03023 0.08 0.021 DBMET03025 0.053 0.04 DBMET03031 0.058 0.034 DBMET03022 0.058 0.034 DBMET03024 0.09 0.018 DBMET03028 | DBMET03028 | |
| 0.085 | 0.02 | 0.085 | GABA A receptor antagonist | 0.076 0.023 DBMET00366 0.056 0.034 DBMET03023 0.056 0.034 DBMET03025 0.049 0.043 DBMET03031 0.056 0.034 DBMET03022 0.057 0.033 DBMET03024 0.061 0.03 DBMET03028 | ||
| 0.078 | 0.014 | 0.084 | Acetylcholine M2 receptor agonist | 0.08 0.013 DBMET00366 0.072 0.018 DBMET03023 0.07 0.02 DBMET03025 0.084 0.011 DBMET03029 0.057 0.032 DBMET03031 0.058 0.031 DBMET02136 0.071 0.018 DBMET03022 0.067 0.022 DBMET03024 0.07 0.019 DBMET03028 0.083 0.012 DBMET03030 0.059 0.03 DBMET03032 | DBMET03029 | |
| 0.065 | 0.002 | 0.075 | Corticosteroid-like | 0.05 0.003 DBMET03018 0.07 0.002 DBMET00366 0.059 0.003 DBMET03023 0.057 0.003 DBMET03025 0.075 0.002 DBMET03029 0.048 0.003 DBMET03031 0.049 0.003 DBMET02136 0.052 0.003 DBMET03022 0.048 0.003 DBMET03024 0.047 0.003 DBMET03028 0.046 0.003 DBMET03030 0.04 0.004 DBMET03032 | DBMET03029 | |
| 0.067 | 0.005 | 0.076 | Glucose-6-phosphate dehydrogenase inhibitor | 0.047 0.014 DBMET03018 0.072 0.005 DBMET00366 0.067 0.005 DBMET03023 0.076 0.004 DBMET03025 0.064 0.006 DBMET03029 0.072 0.005 DBMET03031 0.056 0.008 DBMET02136 0.062 0.006 DBMET03022 0.061 0.007 DBMET03024 0.067 0.005 DBMET03028 0.056 0.008 DBMET03030 0.064 0.006 DBMET03032 | DBMET03025 | |
| 0.112 | 0.052 | 0.164 | Toll-Like receptor 4 antagonist | 0.164 0.014 DBMET03018 0.107 0.059 DBMET00366 0.097 0.075 DBMET03023 0.116 0.048 DBMET03025 0.13 0.034 DBMET03029 0.118 0.046 DBMET03031 0.115 0.049 DBMET03022 0.094 0.081 DBMET03024 0.114 0.05 DBMET03028 0.127 0.037 DBMET03030 0.116 0.048 DBMET03032 | DBMET03018 | |
| 0.097 | 0.04 | 0.127 | Inducible nitric-oxide synthase inhibitor | 0.115 0.027 DBMET00366 0.127 0.022 DBMET03023 0.08 0.062 DBMET03025 0.085 0.054 DBMET03029 0.085 0.054 DBMET02136 0.1 0.037 DBMET03022 0.104 0.033 DBMET03024 | DBMET03023 | |
| 0.08 | 0.025 | 0.148 | Dopamine uptake inhibitor | 0.072 0.029 DBMET00366 0.069 0.031 DBMET03023 0.148 0.01 DBMET03025 0.08 0.025 DBMET03029 0.056 0.042 DBMET03022 0.056 0.042 DBMET03024 0.094 0.02 DBMET03028 0.087 0.023 DBMET03030 | DBMET03025 | |
| 0.187 | 0.134 | 0.187 | 5 Hydroxytryptamine release stimulant | |||
| 0.118 | 0.069 | 0.141 | Adenylate cyclase inhibitor | 0.141 0.051 DBMET00366 0.104 0.081 DBMET03023 0.105 0.08 DBMET03029 0.135 0.056 DBMET03031 | DBMET00366 | |
| 0.141 | 0.092 | 0.141 | Sigma receptor agonist | 0.128 0.105 DBMET03031 0.135 0.097 DBMET03022 0.139 0.094 DBMET03024 0.128 0.105 DBMET03032 | ||
| 0.058 | 0.011 | 0.062 | GABA uptake inhibitor | 0.062 0.009 DBMET00366 0.051 0.015 DBMET03023 0.039 0.028 DBMET03022 0.037 0.031 DBMET03024 | DBMET00366 | |
| 0.089 | 0.042 | 0.141 | Alpha 2a adrenoreceptor antagonist | 0.104 0.034 DBMET00366 0.141 0.024 DBMET03023 0.137 0.025 DBMET03022 0.127 0.027 DBMET03024 | DBMET03023 | |
| 0.097 | 0.05 | 0.097 | Opioid antagonist | 0.076 0.074 DBMET03029 | ||
| 0.18 | 0.133 | 0.231 | RNA-directed DNA polymerase inhibitor | 0.208 0.088 DBMET00366 0.231 0.063 DBMET03023 0.165 0.164 DBMET03025 0.186 0.122 DBMET03031 0.191 0.113 DBMET03022 0.216 0.078 DBMET03024 0.185 0.124 DBMET03032 | DBMET03023 | |
| 0.149 | 0.107 | 0.183 | Phospholipase C inhibitor | 0.153 0.1 DBMET00366 0.174 0.068 DBMET03025 0.179 0.062 DBMET03029 0.183 0.058 DBMET03031 0.138 0.134 DBMET03028 0.144 0.118 DBMET03030 0.146 0.116 DBMET03032 | DBMET03031 | |
| 0.223 | 0.181 | 0.254 | Calcium channel activator | 0.251 0.146 DBMET03023 0.243 0.155 DBMET03029 0.233 0.167 DBMET03031 0.254 0.143 DBMET03022 0.243 0.155 DBMET03024 0.24 0.159 DBMET03030 | DBMET03022 | |
| 0.054 | 0.015 | 0.057 | Dopamine D5 agonist | 0.051 0.017 DBMET00366 0.057 0.013 DBMET03023 | DBMET03023 | |
| 0.176 | 0.14 | 0.269 | Spasmolytic | 0.269 0.083 DBMET03018 0.191 0.128 DBMET00366 0.186 0.132 DBMET03023 0.209 0.112 DBMET03025 0.163 0.151 DBMET03029 0.202 0.118 DBMET03022 0.195 0.124 DBMET03024 0.173 0.143 DBMET03028 0.173 0.143 DBMET03030 | DBMET03018 | |
| 0.074 | 0.037 | 0.09 | Dopamine D1 antagonist | 0.075 0.036 DBMET00366 0.089 0.029 DBMET03023 0.081 0.032 DBMET03022 0.09 0.028 DBMET03024 | DBMET03024 | |
| 0.087 | 0.051 | 0.087 | GABA A receptor agonist | 0.084 0.057 DBMET00366 0.075 0.074 DBMET03022 | ||
| 0.077 | 0.041 | 0.077 | Opioid mu receptor antagonist | |||
| 0.036 | 0.001 | 0.072 | Transcortin receptor antagonist | 0.006 0.004 DBMET03018 0.031 0.001 DBMET00366 0.017 0.001 DBMET03023 0.035 0.001 DBMET03025 0.047 0.001 DBMET03029 0.072 0.001 DBMET03031 0.012 0.002 DBMET02136 0.013 0.002 DBMET03022 0.009 0.003 DBMET03024 0.015 0.002 DBMET03028 0.014 0.002 DBMET03030 0.019 0.001 DBMET03032 | DBMET03031 | |
| 0.086 | 0.053 | 0.201 | Antineoplastic antibiotic | 0.201 0.021 DBMET03018 0.092 0.05 DBMET00366 0.137 0.034 DBMET03023 0.169 0.027 DBMET03025 0.133 0.035 DBMET03029 0.146 0.032 DBMET03031 0.081 0.056 DBMET02136 0.088 0.052 DBMET03022 0.121 0.038 DBMET03024 0.155 0.03 DBMET03028 0.123 0.038 DBMET03030 0.141 0.033 DBMET03032 | DBMET03018 | |
| 0.037 | 0.004 | 0.041 | Progesterone receptor B antagonist | 0.018 0.016 DBMET03018 0.041 0.004 DBMET00366 0.035 0.004 DBMET03023 0.028 0.005 DBMET03025 0.029 0.005 DBMET03029 0.02 0.012 DBMET03031 0.028 0.005 DBMET02136 0.036 0.004 DBMET03022 0.032 0.004 DBMET03024 0.026 0.006 DBMET03028 0.027 0.005 DBMET03030 0.02 0.013 DBMET03032 | DBMET00366 | |
| 0.133 | 0.102 | 0.138 | Ca2+-transporting ATPase inhibitor | 0.129 0.124 DBMET03018 0.138 0.079 DBMET00366 0.136 0.09 DBMET03023 0.131 0.117 DBMET03025 0.136 0.09 DBMET03029 0.136 0.09 DBMET03031 | DBMET00366 | |
| 0.204 | 0.172 | 0.629 | Antithrombotic | 0.629 0.013 DBMET03018 0.221 0.153 DBMET00366 0.222 0.152 DBMET03023 0.208 0.168 DBMET03025 0.222 0.152 DBMET03029 0.256 0.121 DBMET03031 0.294 0.092 DBMET02136 0.201 0.175 DBMET03022 0.2 0.177 DBMET03024 0.234 0.139 DBMET03032 | DBMET03018 | |
| 0.168 | 0.137 | 0.191 | ErbB-1 antagonist | 0.191 0.1 DBMET03022 | DBMET03022 | |
| 0.12 | 0.092 | 0.244 | Protein kinase stimulant | 0.244 0.028 DBMET03018 0.124 0.088 DBMET00366 0.122 0.09 DBMET03025 0.193 0.044 DBMET03029 0.153 0.066 DBMET03031 0.132 0.082 DBMET03022 0.141 0.075 DBMET03024 0.132 0.082 DBMET03028 0.129 0.084 DBMET03030 0.123 0.089 DBMET03032 | DBMET03018 | |
| 0.157 | 0.129 | 0.298 | Hypolipemic | 0.296 0.05 DBMET03018 0.149 0.137 DBMET00366 0.149 0.138 DBMET03023 0.277 0.057 DBMET03025 0.257 0.064 DBMET03029 0.194 0.099 DBMET03031 0.152 0.134 DBMET03024 0.163 0.124 DBMET03028 0.298 0.049 DBMET03030 | DBMET03030 | |
| 0.032 | 0.005 | 0.035 | Thyroid hormone alpha antagonist | 0.035 0.005 DBMET00366 0.03 0.005 DBMET03023 0.02 0.008 DBMET03025 0.032 0.005 DBMET03029 0.021 0.007 DBMET03022 0.02 0.007 DBMET03024 0.015 0.011 DBMET03028 0.019 0.008 DBMET03030 | DBMET00366 | |
| 0.085 | 0.06 | 0.123 | Alpha 2 adrenoreceptor antagonist | 0.098 0.049 DBMET00366 0.123 0.036 DBMET03023 0.123 0.035 DBMET03022 0.121 0.036 DBMET03024 | DBMET03022 | |
| 0.042 | 0.017 | 0.042 | RNA-directed RNA polymerase inhibitor | 0.034 0.024 DBMET00366 | ||
| 0.09 | 0.066 | 0.105 | ABCA1 expression enhancer | 0.087 0.071 DBMET00366 0.105 0.044 DBMET03029 0.088 0.069 DBMET03031 0.095 0.057 DBMET03030 0.084 0.077 DBMET03032 | DBMET03029 | |
| 0.026 | 0.004 | 0.033 | Vitamin D receptor agonist | 0.023 0.005 DBMET03018 0.026 0.004 DBMET00366 0.022 0.005 DBMET03023 0.033 0.003 DBMET03025 0.023 0.005 DBMET03029 0.03 0.004 DBMET03031 0.02 0.007 DBMET02136 0.018 0.009 DBMET03022 0.017 0.01 DBMET03024 0.021 0.006 DBMET03028 0.017 0.011 DBMET03030 0.02 0.007 DBMET03032 | DBMET03025 | |
| 0.083 | 0.062 | 0.083 | NMDA receptor antagonist | |||
| 0.039 | 0.018 | 0.039 | Estrogen-related receptor alpha antagonist | 0.029 0.027 DBMET00366 0.03 0.026 DBMET03025 0.029 0.027 DBMET03029 0.034 0.022 DBMET03031 0.038 0.018 DBMET03022 0.03 0.026 DBMET03028 0.029 0.027 DBMET03030 0.033 0.022 DBMET03032 | ||
| 0.061 | 0.04 | 0.064 | Acetylcholine M3 receptor antagonist | 0.064 0.037 DBMET03025 0.056 0.046 DBMET03029 0.053 0.05 DBMET03031 0.055 0.047 DBMET03028 0.057 0.045 DBMET03030 | DBMET03025 | |
| 0.03 | 0.012 | 0.045 | Hedgehog signaling activator | 0.03 0.013 DBMET00366 0.03 0.012 DBMET03023 0.038 0.005 DBMET03025 0.045 0.004 DBMET03029 0.038 0.005 DBMET03031 0.031 0.012 DBMET03022 0.033 0.008 DBMET03024 0.036 0.006 DBMET03028 0.041 0.004 DBMET03030 0.036 0.006 DBMET03032 | DBMET03029 | |
| 0.122 | 0.107 | 0.145 | CC chemokine 6 receptor antagonist | 0.145 0.029 DBMET03018 0.123 0.104 DBMET00366 0.122 0.107 DBMET03023 | DBMET03018 | |
| 0.153 | 0.141 | 0.414 | Free radical scavenger | 0.414 0.026 DBMET03018 0.194 0.103 DBMET00366 0.244 0.071 DBMET03023 0.204 0.095 DBMET03029 0.171 0.123 DBMET03031 0.227 0.079 DBMET03022 0.231 0.077 DBMET03024 0.152 0.142 DBMET03028 0.173 0.12 DBMET03030 0.228 0.079 DBMET03032 | DBMET03018 | |
| 0.066 | 0.055 | 0.071 | NMDA 2 receptor antagonist | 0.071 0.05 DBMET03025 | DBMET03025 | |
| 0.035 | 0.024 | 0.035 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.024 | 0.014 | 0.085 | Dopamine D1 agonist | 0.029 0.01 DBMET03018 0.032 0.008 DBMET00366 0.085 0.003 DBMET03023 0.021 0.02 DBMET03031 0.023 0.015 DBMET02136 0.026 0.011 DBMET03022 0.053 0.004 DBMET03024 | DBMET03023 | |
| 0.089 | 0.08 | 0.196 | Topoisomerase I inhibitor | 0.196 0.027 DBMET03018 0.085 0.084 DBMET00366 0.094 0.076 DBMET03023 0.118 0.057 DBMET03025 0.094 0.075 DBMET03029 0.115 0.059 DBMET03031 0.099 0.071 DBMET03022 0.094 0.075 DBMET03024 0.12 0.055 DBMET03028 0.085 0.084 DBMET03030 0.094 0.075 DBMET03032 | DBMET03018 | |
| 0.043 | 0.036 | 0.046 | Parathyroid hormone antagonist | 0.044 0.033 DBMET00366 0.044 0.035 DBMET03025 0.045 0.032 DBMET03029 0.046 0.029 DBMET03031 | DBMET03031 | |
| 0.069 | 0.063 | 0.073 | Nicotinic alpha4beta2 receptor antagonist | 0.073 0.058 DBMET00366 | DBMET00366 | |
| 0.012 | 0.008 | 0.013 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.013 0.008 DBMET00366 0.012 0.008 DBMET03023 | DBMET00366 | |
| 0.053 | 0.05 | 0.057 | Pregnane X receptor antagonist | 0.057 0.037 DBMET00366 0.054 0.048 DBMET03031 0.057 0.039 DBMET03022 0.055 0.045 DBMET03024 0.054 0.047 DBMET03032 | DBMET03022 | |
| 0.014 | 0.013 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.065 | 0.067 | 0.124 | Topoisomerase II alpha inhibitor | 0.124 0.029 DBMET03018 0.112 0.033 DBMET03023 0.081 0.052 DBMET03025 0.07 0.061 DBMET03022 0.109 0.034 DBMET03024 0.078 0.054 DBMET03028 | DBMET03018 | |
| 0.047 | 0.051 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | 0.05 0.043 DBMET00366 | DBMET00366 | |
| 0.019 | 0.025 | 0.022 | Vitamin D receptor antagonist | 0.021 0.017 DBMET03025 0.022 0.016 DBMET03029 0.021 0.017 DBMET03031 | DBMET03029 | |
| 0.099 | 0.105 | 0.261 | Cyclooxygenase 3 inhibitor | 0.261 0.008 DBMET03018 0.123 0.074 DBMET03029 0.108 0.091 DBMET03022 0.108 0.092 DBMET03024 0.125 0.072 DBMET03030 | DBMET03018 | |
| 0.084 | 0.093 | 0.121 | Alpha 2b adrenoreceptor antagonist | 0.111 0.065 DBMET03023 0.111 0.065 DBMET03022 0.121 0.057 DBMET03024 | DBMET03024 | |
| 0.015 | 0.028 | 0.025 | Antibiotic Anthracycline-like | 0.025 0.005 DBMET03018 0.022 0.008 DBMET03025 0.019 0.014 DBMET03024 0.02 0.01 DBMET03028 0.018 0.016 DBMET03030 0.018 0.016 DBMET03032 | DBMET03018 | |
| 0.211 | 0.224 | 0.227 | Analgesic | 0.227 0.206 DBMET03025 | DBMET03025 | |
| 0.036 | 0.051 | 0.083 | Dopamine transporter inhibitor | 0.083 0.016 DBMET03025 0.049 0.033 DBMET03028 | DBMET03025 | |
| 0.012 | 0.03 | 0.017 | Telomerase stimulant | 0.017 0.012 DBMET03018 0.016 0.015 DBMET03025 0.016 0.015 DBMET03029 0.016 0.015 DBMET03031 | DBMET03018 | |
| 0.028 | 0.047 | 0.069 | Dopamine D5 antagonist | 0.069 0.015 DBMET03023 0.04 0.032 DBMET03024 | DBMET03023 | |
| 0.104 | 0.126 | 0.139 | Neurotrophic factor | 0.12 0.096 DBMET00366 0.136 0.073 DBMET03025 0.139 0.07 DBMET03029 0.126 0.086 DBMET03031 0.119 0.097 DBMET03022 0.117 0.099 DBMET03030 0.12 0.095 DBMET03032 | DBMET03029 | |
| 0.088 | 0.11 | 0.309 | Amylase inhibitor | 0.309 0.017 DBMET03018 0.111 0.088 DBMET03023 0.107 0.09 DBMET03031 0.107 0.091 DBMET03022 0.111 0.087 DBMET03024 | DBMET03018 | |
| 0.12 | 0.143 | 0.559 | Angiogenesis stimulant | 0.559 0.009 DBMET03018 0.135 0.132 DBMET00366 0.148 0.124 DBMET03023 0.181 0.104 DBMET03025 0.236 0.076 DBMET03029 0.205 0.092 DBMET03031 0.407 0.02 DBMET02136 0.139 0.13 DBMET03022 0.17 0.111 DBMET03028 0.239 0.075 DBMET03030 0.192 0.098 DBMET03032 | DBMET03018 | |
| 0.029 | 0.052 | 0.043 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.043 0.036 DBMET03023 | DBMET03023 | |
| 0.071 | 0.095 | 0.133 | Transcription factor NF kappa B stimulant | 0.133 0.02 DBMET03018 0.079 0.072 DBMET03025 0.101 0.038 DBMET03029 0.082 0.065 DBMET03031 0.082 0.064 DBMET03030 | DBMET03018 | |
| 0.015 | 0.043 | 0.047 | Protein 30S ribosomal subunit inhibitor | 0.047 0.009 DBMET03018 | DBMET03018 | |
| 0.04 | 0.068 | 0.062 | NMDA 2B receptor antagonist | 0.062 0.03 DBMET03025 | DBMET03025 | |
| 0.022 | 0.054 | 0.064 | Farnesoid X receptor agonist | 0.064 0.009 DBMET03029 0.035 0.029 DBMET03031 0.035 0.031 DBMET03028 0.05 0.014 DBMET03030 | DBMET03029 | |
| 0.189 | 0.222 | 0.293 | Antiobesity | 0.286 0.126 DBMET03018 0.293 0.121 DBMET03029 0.267 0.142 DBMET02136 | DBMET03029 | |
| 0.032 | 0.066 | 0.049 | Microtubule stabilization | 0.049 0.03 DBMET03018 0.042 0.039 DBMET03025 0.048 0.031 DBMET03029 0.042 0.038 DBMET03031 0.043 0.037 DBMET03028 0.042 0.038 DBMET03030 | DBMET03018 | |
| 0.1 | 0.138 | 0.127 | Cholinergic | 0.124 0.103 DBMET03022 0.127 0.1 DBMET03024 | DBMET03024 | |
| 0.042 | 0.089 | 0.072 | Nitric oxide donor | 0.072 0.031 DBMET03018 0.06 0.048 DBMET03029 0.064 0.041 DBMET03031 0.059 0.049 DBMET03030 | DBMET03018 | |
| 0.006 | 0.055 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 DBMET03018 | DBMET03018 | |
| 0.052 | 0.101 | 0.059 | Prolactin release inhibitor | 0.059 0.058 DBMET03023 | DBMET03023 | |
| 0.211 | 0.261 | 0.685 | Cyclophilin D inhibitor | 0.685 0.016 DBMET03018 0.241 0.224 DBMET03023 0.329 0.139 DBMET03025 0.369 0.109 DBMET03029 0.247 0.217 DBMET02136 0.257 0.205 DBMET03028 0.268 0.193 DBMET03030 | DBMET03018 | |
| 0.036 | 0.094 | 0.194 | Dopamine agonist | 0.194 0.01 DBMET03023 0.104 0.026 DBMET03024 | DBMET03023 | |
| 0.039 | 0.098 | 0.05 | Alpha 1L adrenoreceptor antagonist | 0.05 0.042 DBMET03028 0.05 0.042 DBMET03030 0.05 0.042 DBMET03032 | DBMET03032 | |
| 0.012 | 0.073 | 0.065 | Sodium/glucose cotransporter 2 inhibitor | 0.065 0.005 DBMET03018 | DBMET03018 | |
| 0.068 | 0.129 | 0.166 | Topoisomerase II inhibitor | 0.166 0.043 DBMET03018 0.13 0.06 DBMET03023 0.098 0.088 DBMET03025 0.114 0.072 DBMET03024 0.101 0.085 DBMET03028 | DBMET03018 | |
| 0.049 | 0.116 | 0.102 | CDC25A inhibitor | 0.102 0.026 DBMET03023 | DBMET03023 | |
| 0.078 | 0.146 | 0.109 | Acetylcholinesterase inhibitor | 0.105 0.097 DBMET03022 0.109 0.09 DBMET03024 | DBMET03024 | |
| 0.166 | 0.236 | 0.188 | 5 Hydroxytryptamine uptake stimulant | 0.188 0.178 DBMET00366 | DBMET00366 | |
| 0.018 | 0.101 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 DBMET03018 0.026 0.021 DBMET02136 | DBMET03018 | |
| 0.016 | 0.101 | 0.09 | Dopamine D2 agonist | 0.09 0.012 DBMET03023 0.043 0.032 DBMET03024 | DBMET03023 | |
| 0.013 | 0.1 | 0.047 | Sodium/glucose cotransporter inhibitor | 0.047 0.005 DBMET03018 | DBMET03018 | |
| 0.061 | 0.149 | 0.102 | Chelator | 0.102 0.075 DBMET03023 | DBMET03023 | |
| 0.065 | 0.16 | 0.144 | Beta glucuronidase inhibitor | 0.144 0.028 DBMET03018 | DBMET03018 | |
| 0.007 | 0.103 | 0.027 | Squalene synthetase inhibitor | 0.027 0.026 DBMET03018 | DBMET03018 | |
| 0.14 | 0.253 | 0.398 | Immunomodulator | 0.398 0.044 DBMET03018 0.242 0.122 DBMET03025 0.196 0.169 DBMET03029 0.227 0.135 DBMET02136 | DBMET03018 | |
| 0.013 | 0.127 | 0.036 | HMG CoA reductase inhibitor | 0.036 0.02 DBMET03030 | DBMET03030 | |
| 0.1 | 0.219 | 0.404 | Immunostimulant | 0.404 0.048 DBMET03018 0.177 0.135 DBMET03029 | DBMET03018 | |
| 0.011 | 0.132 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.034 0.008 DBMET02136 | DBMET02136 | |
| 0.048 | 0.173 | 0.174 | Expectorant | 0.174 0.027 DBMET03018 0.087 0.085 DBMET03029 | DBMET03018 | |
| 0.016 | 0.142 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.023 DBMET02136 | DBMET02136 | |
| 0.038 | 0.196 | 0.13 | M18 aspartyl aminopeptidase inhibitor | 0.13 0.063 DBMET03023 | DBMET03023 | |
| 0.097 | 0.259 | 0.198 | ATPase inhibitor | 0.198 0.039 DBMET03018 | DBMET03018 | |
| 0.077 | 0.244 | 0.236 | Antimitotic | 0.223 0.072 DBMET03022 0.236 0.065 DBMET03024 0.203 0.082 DBMET03028 | DBMET03024 | |
| 0.017 | 0.201 | 0.082 | Protein 50S ribosomal subunit inhibitor | 0.082 0.019 DBMET03018 | DBMET03018 | |
| 0.019 | 0.211 | 0.055 | HIV-1 integrase (3'-Processing) inhibitor | 0.055 0.054 DBMET03023 | DBMET03023 | |
| 0.045 | 0.24 | 0.158 | AMP-activated protein kinase stimulant | 0.158 0.023 DBMET03018 | DBMET03018 | |
| 0.065 | 0.291 | 0.214 | Interleukin agonist | 0.214 0.108 DBMET03018 | DBMET03018 | |
| 0.016 | 0.268 | 0.06 | Antibiotic Aminoglycoside-like | 0.06 0.009 DBMET03018 | DBMET03018 | |
| 0.094 | 0.347 | 0.21 | Angiogenesis inhibitor | 0.21 0.158 DBMET03018 0.203 0.166 DBMET02136 | DBMET03018 | |
| 0.066 | 0.337 | 0.125 | Growth hormone agonist | 0.125 0.113 DBMET03029 | DBMET03029 | |
| 0.02 | 0.293 | 0.06 | Glucose-6-phosphate translocase inhibitor | 0.06 0.024 DBMET03018 | DBMET03018 | |
| 0.046 | 0.362 | 0.078 | T cell inhibitor | 0.078 0.073 DBMET03018 | DBMET03018 | |
| 0.051 | 0.37 | 0.127 | Hexokinase inhibitor | 0.127 0.109 DBMET03018 | DBMET03018 | |
| 0.018 | 0.342 | 0.068 | Heparanase inhibitor | 0.068 0.013 DBMET03018 | DBMET03018 | |
| 0.048 | 0.386 | 0.296 | Platelet adhesion inhibitor | 0.296 0.035 DBMET03018 0.142 0.116 DBMET02136 | DBMET03018 | |
| 0.068 | 0.421 | 0.472 | Hypoglycemic | 0.472 0.018 DBMET03018 | DBMET03018 | |
| 0.084 | 0.437 | 0.53 | Antibacterial | 0.53 0.033 DBMET03018 | DBMET03018 | |
| 0.026 | 0.411 | 0.095 | Multidrug resistance-associated protein 1 inhibitor | 0.095 0.087 DBMET02136 | DBMET02136 | |
| 0.087 | 0.537 | 0.318 | Peptidyltransferase inhibitor | 0.318 0.019 DBMET03018 | DBMET03018 | |
| 0.018 | 0.488 | 0.094 | ATPase (Vacuolar H+) inhibitor | 0.094 0.049 DBMET03018 0.083 0.072 DBMET03030 0.083 0.072 DBMET03032 | DBMET03018 | |
| 0.026 | 0.519 | 0.114 | Cell wall synthesis inhibitor | 0.114 0.109 DBMET03018 | DBMET03018 | |
| 0.026 | 0.523 | 0.183 | Platelet antagonist | 0.183 0.115 DBMET03018 | DBMET03018 | |
| 0.032 | 0.538 | 0.261 | Tumour necrosis factor alpha release inhibitor | 0.261 0.07 DBMET03018 | DBMET03018 | |
| 0.028 | 0.553 | 0.152 | Hemostatic | 0.152 0.065 DBMET03018 | DBMET03018 | |
| 0.028 | 0.561 | 0.154 | Insulin secretagoues | 0.154 0.07 DBMET03018 | DBMET03018 | |
| 0.017 | 0.561 | 0.192 | Thrombolytic | 0.192 0.056 DBMET03018 | DBMET03018 | |
| 0.024 | 0.589 | 0.156 | Vasodilator | 0.156 0.148 DBMET03018 | DBMET03018 | |
| 0.01 | 0.58 | 0.148 | Cholecystokinin B agonist | 0.148 0.005 DBMET02136 | DBMET02136 | |
| 0.003 | 0.607 | 0.028 | Cholecystokinin B antagonist | 0.028 0.024 DBMET02136 | DBMET02136 | |
| 0.005 | 0.635 | 0.26 | Selectin antagonist | 0.26 0.008 DBMET03018 0.086 0.034 DBMET02136 | DBMET03018 | |
| 0.011 | 0.764 | 0.109 | Cell adhesion inhibitor | 0.109 0.075 DBMET03018 | DBMET03018 | |
| 0.003 | 0.763 | 0.039 | Cholecystokinin A antagonist | 0.039 0.025 DBMET02136 | DBMET02136 | |
| 0.01 | 0.851 | 0.048 | Factor IXa inhibitor | 0.048 0.041 DBMET02136 | DBMET02136 | |
| 0.005 | 0.853 | 0.249 | Anticoagulant | 0.249 0.039 DBMET02136 | DBMET02136 | |
| 0.002 | 0.908 | 0.081 | Cholecystokinin agonist | 0.081 0.005 DBMET02136 | DBMET02136 | |
| 0.002 | 0.945 | 0.037 | Cholecystokinin A agonist | 0.037 0.005 DBMET02136 | DBMET02136 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |